Testosterone Cholesterol ,100 mg Pellet, Compounded by: Wells Pharmacy Network
Published November 16, 2016 · Recall initiated: September 19, 2016
Summary
FDA records drug Class III recall D-0127-2017, published November 16, 2016 and initiated September 19, 2016. Recalling firm: Wells Pharmacy Network, LLC; Status: Terminated; Reported quantity: 1 pellet; Lot: Lot Number 06072016@5, BUD 12/04/2016. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent and Subpotent drugs
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Wells Pharmacy Network, LLC
- Distributor
- U.S.
- Lot
- Lot Number 06072016@5, BUD 12/04/2016
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATestosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDATestosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDATestosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDAEstradiol 12.5 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDAEstradiol 3 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDATANDEM (TM) INTL COCR SHELL UHMWPE LINER BIPOLAR, REF NUMBERS: 71324038, 71324039, 71324040, 71324041,November 9, 2016
Questions about this recall
Was Testosterone Cholesterol ,100 mg Pellet, Compounded by: Wells Pharmacy Network recalled?
Yes. FDA published recall D-0127-2017 on November 16, 2016. Reported hazard: Superpotent and Subpotent drugs
What should I do if I have this product?
Voluntary: Firm initiated · Telephone